BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 10566625)

  • 21. Endocrine effects of oral dehydroepiandrosterone in men with HIV infection: a prospective, randomized, double-blind, placebo-controlled trial.
    Poretsky L; Brillon DJ; Ferrando S; Chiu J; McElhiney M; Ferenczi A; Sison MC; Haller I; Rabkin J
    Metabolism; 2006 Jul; 55(7):858-70. PubMed ID: 16784956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Supplementation with DHEA: effect on muscle size, strength, quality of life, and lipids.
    Dayal M; Sammel MD; Zhao J; Hummel AC; Vandenbourne K; Barnhart KT
    J Womens Health (Larchmt); 2005 Jun; 14(5):391-400. PubMed ID: 15989411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dehydroepiandrosterone replacement in healthy men with age-related decline of DHEA-S: effects on fat distribution, insulin sensitivity and lipid metabolism.
    Jedrzejuk D; Medras M; Milewicz A; Demissie M
    Aging Male; 2003 Sep; 6(3):151-6. PubMed ID: 14628495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dehydroepiandrosterone replacement administration: pharmacokinetic and pharmacodynamic studies in healthy elderly subjects.
    Legrain S; Massien C; Lahlou N; Roger M; Debuire B; Diquet B; Chatellier G; Azizi M; Faucounau V; Porchet H; Forette F; Baulieu EE
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3208-17. PubMed ID: 10999810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DHEA treatment for HIV+ patients: effects on mood, androgenic and anabolic parameters.
    Rabkin JG; Ferrando SJ; Wagner GJ; Rabkin R
    Psychoneuroendocrinology; 2000 Jan; 25(1):53-68. PubMed ID: 10633535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of dehydroepiandrosterone (DHEA) on cardiovascular risk factors in older women with frailty characteristics.
    Boxer RS; Kleppinger A; Brindisi J; Feinn R; Burleson JA; Kenny AM
    Age Ageing; 2010 Jul; 39(4):451-8. PubMed ID: 20484057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low serum levels of sex steroids are associated with disease characteristics in primary Sjogren's syndrome; supplementation with dehydroepiandrosterone restores the concentrations.
    Forsblad-d'Elia H; Carlsten H; Labrie F; Konttinen YT; Ohlsson C
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2044-51. PubMed ID: 19318446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women.
    Mortola JF; Yen SS
    J Clin Endocrinol Metab; 1990 Sep; 71(3):696-704. PubMed ID: 2144295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association of androgenic sex steroids with serum lipid levels in postmenopausal women.
    Noyan V; Yucel A; Sagsoz N
    Acta Obstet Gynecol Scand; 2004 May; 83(5):487-90. PubMed ID: 15059164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of a 3-week dehydroepiandrosterone administration on sleep, sex steroids and multiple 24-h hormonal profiles in postmenopausal women: a pilot study.
    Caufriez A; Leproult R; L'Hermite-Balériaux M; Kerkhofs M; Copinschi G
    Clin Endocrinol (Oxf); 2013 Nov; 79(5):716-24. PubMed ID: 23488643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized trial of oral DHEA treatment for sexual function, well-being, and menopausal symptoms in postmenopausal women with low libido.
    Panjari M; Bell RJ; Jane F; Wolfe R; Adams J; Morrow C; Davis SR
    J Sex Med; 2009 Sep; 6(9):2579-90. PubMed ID: 19619146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age.
    Guazzo EP; Kirkpatrick PJ; Goodyer IM; Shiers HM; Herbert J
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3951-60. PubMed ID: 8923843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of dehydroepiandrosterone replacement therapy on bone mineral density in older adults: a randomized, controlled trial.
    Jankowski CM; Gozansky WS; Schwartz RS; Dahl DJ; Kittelson JM; Scott SM; Van Pelt RE; Kohrt WM
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2986-93. PubMed ID: 16735495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antioxidant activity of dioscorea and dehydroepiandrosterone (DHEA) in older humans.
    Araghiniknam M; Chung S; Nelson-White T; Eskelson C; Watson RR
    Life Sci; 1996; 59(11):PL147-57. PubMed ID: 8795709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized double-blinded placebo-controlled trial on the effect of dehydroepiandrosterone for 16 weeks on ovarian response markers in women with primary ovarian insufficiency.
    Yeung TW; Li RH; Lee VC; Ho PC; Ng EH
    J Clin Endocrinol Metab; 2013 Jan; 98(1):380-8. PubMed ID: 23144466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of short-term DHEA intake on hormonal responses in young recreationally trained athletes: modulation by gender.
    Collomp K; Buisson C; Gravisse N; Belgherbi S; Labsy Z; Do MC; Gagey O; Dufay S; Vibarel-Rebot N; Audran M
    Endocrine; 2018 Mar; 59(3):538-546. PubMed ID: 29322301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Adrenopause and dehydroepiandrosterone: pharmacological therapy versus replacement therapy].
    Römmler A
    Gynakol Geburtshilfliche Rundsch; 2003 Apr; 43(2):79-90. PubMed ID: 12649580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens.
    Arlt W; Haas J; Callies F; Reincke M; Hübler D; Oettel M; Ernst M; Schulte HM; Allolio B
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2170-6. PubMed ID: 10372727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression.
    Arlt W; Justl HG; Callies F; Reincke M; Hübler D; Oettel M; Ernst M; Schulte HM; Allolio B
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1928-34. PubMed ID: 9626121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term low-dose dehydroepiandrosterone oral supplementation in early and late postmenopausal women modulates endocrine parameters and synthesis of neuroactive steroids.
    Genazzani AD; Stomati M; Bernardi F; Pieri M; Rovati L; Genazzani AR
    Fertil Steril; 2003 Dec; 80(6):1495-501. PubMed ID: 14667889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.